Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of moxaverine effects on ocular blood flow in AMD, POAG, and healthy subjects
2007-005607-18Phase 2Completed
- Sponsor
- URSAPHARM
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of moxaverine in age-related macular degeneration (AMD), open-angle glaucoma (OAG), sponsored by URSAPHARM. Started Mar 2008; status: completed.
02
Drugs
moxaverine
03
Conditions
age-related macular degeneration (AMD)open-angle glaucoma (OAG)
Beyond the preview
Go deeper on 2007-005607-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005607-18.